EPRXF
Price:
$3.04
Market Cap:
$159.95M
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treating canine and equine osteoarthritis. Its products in development also include EP-201, an antibiotic for post-surgical site infections; and EP-105, an extended-release post-surgical anesthetic for post-surgical pain. In addition, the company develops product candidates for oncology. The company was formerly known as ...[Read more]
Industry
Biotechnology
IPO Date
2021-08-03
Stock Exchange
PNK
Ticker
EPRXF
According to Eupraxia Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current ROE is -182.55%. This represents a change of 129.22% compared to the average of -79.64% of the last 4 quarters.
The mean historical ROE of Eupraxia Pharmaceuticals Inc. over the last ten years is -267.72%. The current -182.55% ROE has changed -31.81% with respect to the historical average. Over the past ten years (40 quarters), EPRXF's ROE was at its highest in in the September 2020 quarter at 4.96%. The ROE was at its lowest in in the December 2023 quarter at -184.83%.
Average
-267.72%
Median
-72.22%
Minimum
-1687.19%
Maximum
119.65%
Discovering the peaks and valleys of Eupraxia Pharmaceuticals Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 832.50%
Maximum Annual ROE = 119.65%
Minimum Annual Increase = -698.36%
Minimum Annual ROE = -1687.19%
Year | ROE | Change |
---|---|---|
2023 | -1687.19% | 832.50% |
2022 | -180.93% | 60.45% |
2021 | -112.77% | -698.36% |
2020 | 18.85% | -53.54% |
2019 | 40.57% | -66.10% |
2018 | 119.65% | -265.66% |
The current ROE of Eupraxia Pharmaceuticals Inc. (EPRXF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-660.30%
5-year avg
-384.30%
10-year avg
-267.72%
Eupraxia Pharmaceuticals Inc.’s ROE is less than Adynxx, Inc. (0%), less than Ascletis Pharma Inc. (0%), greater than AVAX Technologies, Inc. (-11.43%), greater than Eliem Therapeutics, Inc. (-344.15%), less than Inhibrx Biosciences, Inc. (0%), less than Merrimack Pharmaceuticals, Inc. (1.45%), greater than Celcuity Inc. (-35.28%), greater than Enliven Therapeutics, Inc. (-62.66%), greater than Transgene SA (-29.46%), greater than Champions Oncology, Inc. (-295.34%), less than MAIA Biotechnology, Inc. (66.22%), less than Lumos Pharma, Inc. (20.47%), greater than Processa Pharmaceuticals, Inc. (-233.03%), greater than Alpha Cognition Inc. (-195.22%), less than Acurx Pharmaceuticals, Inc. (666.93%), greater than Fennec Pharmaceuticals Inc. (-67679.28%), less than null (31.99%),
Company | ROE | Market cap |
---|---|---|
0% | $600.00 | |
0% | $242.35M | |
-11.43% | $6.89K | |
-344.15% | $342.68M | |
0% | $209.76M | |
1.45% | $223.97M | |
-35.28% | $465.23M | |
-62.66% | $1.13B | |
-29.46% | $209.81M | |
-295.34% | $108.76M | |
66.22% | $50.41M | |
20.47% | $37.54M | |
-233.03% | $2.85M | |
-195.22% | $35.66M | |
666.93% | $14.78M | |
-67679.28% | $169.78M | |
31.99% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eupraxia Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eupraxia Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Eupraxia Pharmaceuticals Inc.'s ROE?
How is the ROE calculated for Eupraxia Pharmaceuticals Inc. (EPRXF)?
What is the highest ROE for Eupraxia Pharmaceuticals Inc. (EPRXF)?
What is the 3-year average ROE for Eupraxia Pharmaceuticals Inc. (EPRXF)?
What is the 5-year average ROE for Eupraxia Pharmaceuticals Inc. (EPRXF)?
How does the current ROE for Eupraxia Pharmaceuticals Inc. (EPRXF) compare to its historical average?